Murine orthotopic model for the assessment of chemoradiotherapeutic interventions in rectal cancer

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A murine orthotopic model for the study of colon cancer has been described earlier. However, for the study of rectal cancer, three issues remain: (i) the relative sensitivity of the implanted tumors to ionizing radiation (IR); (ii) the location of the tumor for the delivery of external beam IR; and (iii) the assessment of a given modality over time before necropsy. In this protocol, we have modified an orthotopic model for colon cancer described earlier for the specific assessment of chemoradiation in rectal cancer by (i) cecal transplantation of tumors with a known response to IR; (ii) securing the tumor to the lateral abdominal wall with a permanent suture for the administration of IR; and (iii) transfection of cells with luciferase before tumor implantation for the assessment of the chemoradiotherapeutic interventions over time by bioluminescence imaging before the end on the study. This technique allows targeted delivery of IR in an intraperitoneal tumor. Imaging throughout the course of the treatment is possible such that the timing of chemoradiation can be determined and permits comparison between groups before the end of the treatment. This model represents a modified technique that allows the assessment of chemoradiotherapeutic interventions in rectal cancer.

Original languageEnglish (US)
Pages (from-to)371-376
Number of pages6
JournalAnti-Cancer Drugs
Volume22
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Rectal Neoplasms
Ionizing Radiation
Neoplasms
Colonic Neoplasms
Abdominal Wall
Luciferases
Sutures
Transfection
Transplantation

Keywords

  • HT-29 colorectal cancer cells
  • in-vivo imaging system
  • ionizing radiation
  • pathological complete response
  • radiation enteritis
  • radioresistance

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Cancer Research
  • Oncology

Cite this

Murine orthotopic model for the assessment of chemoradiotherapeutic interventions in rectal cancer. / Huerta, Sergio; Gao, Xiaohuan; Saha, Debabrata.

In: Anti-Cancer Drugs, Vol. 22, No. 4, 04.2011, p. 371-376.

Research output: Contribution to journalArticle

@article{32dc1875b4d54975af13ccc0df9024f2,
title = "Murine orthotopic model for the assessment of chemoradiotherapeutic interventions in rectal cancer",
abstract = "A murine orthotopic model for the study of colon cancer has been described earlier. However, for the study of rectal cancer, three issues remain: (i) the relative sensitivity of the implanted tumors to ionizing radiation (IR); (ii) the location of the tumor for the delivery of external beam IR; and (iii) the assessment of a given modality over time before necropsy. In this protocol, we have modified an orthotopic model for colon cancer described earlier for the specific assessment of chemoradiation in rectal cancer by (i) cecal transplantation of tumors with a known response to IR; (ii) securing the tumor to the lateral abdominal wall with a permanent suture for the administration of IR; and (iii) transfection of cells with luciferase before tumor implantation for the assessment of the chemoradiotherapeutic interventions over time by bioluminescence imaging before the end on the study. This technique allows targeted delivery of IR in an intraperitoneal tumor. Imaging throughout the course of the treatment is possible such that the timing of chemoradiation can be determined and permits comparison between groups before the end of the treatment. This model represents a modified technique that allows the assessment of chemoradiotherapeutic interventions in rectal cancer.",
keywords = "HT-29 colorectal cancer cells, in-vivo imaging system, ionizing radiation, pathological complete response, radiation enteritis, radioresistance",
author = "Sergio Huerta and Xiaohuan Gao and Debabrata Saha",
year = "2011",
month = "4",
doi = "10.1097/CAD.0b013e32834367c7",
language = "English (US)",
volume = "22",
pages = "371--376",
journal = "Anti-Cancer Drugs",
issn = "0959-4973",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Murine orthotopic model for the assessment of chemoradiotherapeutic interventions in rectal cancer

AU - Huerta, Sergio

AU - Gao, Xiaohuan

AU - Saha, Debabrata

PY - 2011/4

Y1 - 2011/4

N2 - A murine orthotopic model for the study of colon cancer has been described earlier. However, for the study of rectal cancer, three issues remain: (i) the relative sensitivity of the implanted tumors to ionizing radiation (IR); (ii) the location of the tumor for the delivery of external beam IR; and (iii) the assessment of a given modality over time before necropsy. In this protocol, we have modified an orthotopic model for colon cancer described earlier for the specific assessment of chemoradiation in rectal cancer by (i) cecal transplantation of tumors with a known response to IR; (ii) securing the tumor to the lateral abdominal wall with a permanent suture for the administration of IR; and (iii) transfection of cells with luciferase before tumor implantation for the assessment of the chemoradiotherapeutic interventions over time by bioluminescence imaging before the end on the study. This technique allows targeted delivery of IR in an intraperitoneal tumor. Imaging throughout the course of the treatment is possible such that the timing of chemoradiation can be determined and permits comparison between groups before the end of the treatment. This model represents a modified technique that allows the assessment of chemoradiotherapeutic interventions in rectal cancer.

AB - A murine orthotopic model for the study of colon cancer has been described earlier. However, for the study of rectal cancer, three issues remain: (i) the relative sensitivity of the implanted tumors to ionizing radiation (IR); (ii) the location of the tumor for the delivery of external beam IR; and (iii) the assessment of a given modality over time before necropsy. In this protocol, we have modified an orthotopic model for colon cancer described earlier for the specific assessment of chemoradiation in rectal cancer by (i) cecal transplantation of tumors with a known response to IR; (ii) securing the tumor to the lateral abdominal wall with a permanent suture for the administration of IR; and (iii) transfection of cells with luciferase before tumor implantation for the assessment of the chemoradiotherapeutic interventions over time by bioluminescence imaging before the end on the study. This technique allows targeted delivery of IR in an intraperitoneal tumor. Imaging throughout the course of the treatment is possible such that the timing of chemoradiation can be determined and permits comparison between groups before the end of the treatment. This model represents a modified technique that allows the assessment of chemoradiotherapeutic interventions in rectal cancer.

KW - HT-29 colorectal cancer cells

KW - in-vivo imaging system

KW - ionizing radiation

KW - pathological complete response

KW - radiation enteritis

KW - radioresistance

UR - http://www.scopus.com/inward/record.url?scp=79952988260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952988260&partnerID=8YFLogxK

U2 - 10.1097/CAD.0b013e32834367c7

DO - 10.1097/CAD.0b013e32834367c7

M3 - Article

VL - 22

SP - 371

EP - 376

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

SN - 0959-4973

IS - 4

ER -